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Abstract
Background: The bed nucleus of the stria terminalis (BNST) contains the highest density of corticotropin-releasing
factor (CRF)-producing neurons in the brain. CRF-immunoreactive neurons show a female-biased sexual
dimorphism in the dorsolateral BNST in the rat. Since CRF neurons cannot be immunostained clearly with available
CRF antibodies in the mouse, we used a mouse line, in which modified yellow fluorescent protein (Venus) was
inserted to the CRF gene, and the Neo cassette was removed, to examine the morphological characteristics of CRF
neurons in the dorsolateral BNST. Developmental changes of CRF neurons were examined from postnatal stages to
adulthood. Gonadectomy (GDX) was carried out in adult male and female mice to examine the effects of sex
steroids on the number of CRF neurons in the dorsolateral BNST.
Methods: The number of Venus-expressing neurons, stained by immunofluorescence, was compared between
male and female mice over the course of development. GDX was carried out in adult mice. Immunohistochemistry,
in combination with Nissl staining, was carried out, and the effects of sex or gonadal steroids were examined by
estimating the number of Venus-expressing neurons, as well as the total number of neurons or glial cells, in each
BNST subnucleus, using a stereological method.
Results: Most Venus-expressing neurons co-expressed Crf mRNA in the dorsolateral BNST. They constitute a group of
neurons without calbindin immunoreactivity, which makes a contrast to the principal nucleus of the BNST that is
characterized by calbindin immunostaining. In the dorsolateral BNST, the number of Venus-expressing neurons
increased across developmental stages until adulthood. Sexual difference in the number of Venus-expressing neurons
was not evident by postnatal day 5. In adulthood, however, there was a significant female predominance in the
number of Venus expressing neurons in two subnuclei of the dorsolateral BNST, i.e., the oval nucleus of the
BNST (ovBNST) and the anterolateral BNST (alBNST). The number of Venus-expressing neurons was smaller significantly
in ovariectomized females compared with proestrous females in either ovBNST or alBNST, and greater significantly in
orchiectomized males compared with gonadally intact males in ovBNST. The total number of neurons was also greater
significantly in females than in males in ovBNST and alBNST, but it was not affected by GDX.
Conclusion: Venus-expressing CRF neurons showed female-biased sexual dimorphism in ovBNST and alBNST of the
mouse. Expression of Venus in these subnuclei was controlled by gonadal steroids.
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Background
Corticotropin-releasing factor (CRF) neurons, in the para-
ventricular nucleus of the hypothalamus (PVH), play a piv-
otal role in the regulation of hypothalamic-pituitary-adrenal
axis and control synthesis of glucocorticoid that is essential
for protecting an organism from stress [1]. CRF neurons
are also distributed in the brain regions outside the PVH
such as the cerebral cortex [2], the inferior olivary nucleus
[3], Barrington’s nucleus [4], the central nucleus of the
amygdala (CeA) [5], and the bed nucleus of the stria termi-
nalis (BNST) [6]. In the rat, CRF neurons in the brain are
readily detectable by immunohistochemistry, and the stain-
ing becomes more intense after colchicine injection into
the brain ventricle to block an axonal flow. However, CRF
neurons cannot be immunostained clearly with any avail-
able CRF antibody in most brain regions in the mouse, even
with colchicine treatment [7, 8]. We could overcome this
difficulty by using a mouse line, in which modified yellow
fluorescent protein (Venus) was inserted into the CRF gen-
omic locus (CRF-Venus) [8]. Subsequently, another mouse
line (CRF-VenusΔNeo) was generated by deletion of the
pgk-1 promoter-driven neomycin phosphotransferase gene
(Neo cassette) from the CRF-Venus genome, and the Venus
expression was profoundly enhanced in the
CRF-VenusΔNeo compared with the CRF-Venus [8, 9]. Re-
cently, distribution of CRF neurons was unraveled through-
out the mouse brain by staining Venus, in the
CRF-VenusΔNeo, with anti-green fluorescent protein
(GFP) antibody that cross-reacts with Venus [8, 9].
The BNST is one of the brain regions that contain the
highest density of CRF neurons in the mouse [9] and
the rat [6, 10]. It is primarily divided into anterior
and posterior divisions, and CRF neurons are reported
to be distributed in the former in the rat. CRF neu-
rons are also reported to be expressed most promin-
ently in the oval nucleus of the BNST (ovBNST),
among other subnuclei in the anterior division of
BNST, in the rat [6, 10], which is located in the cen-
tral portion of the dorsolateral BNST.
The BNST is structurally a continuum of the amygdal-
oid nucleus and referred to as the “extended amygdala.”
The basolateral amygdala and two downstream struc-
tures, the CeA and the BNST, are implicated in anxiety
and fear [11, 12]. The CeA was proposed to play a role
in short-duration fear responses, whereas the BNST in
sustained responses, in experimental animals [11, 12]. By
functional magnetic resonance imaging studies in
humans, BNST activation was related to the anticipation
of threat [13].
It was reported by Fukushima and colleagues that the
number of CRF neurons in the dorsolateral BNST of the
rat is greater in females than in males [14]. Interestingly,
the number of CRF neurons in dorsolateral BNST of fe-
male rats decreased by treatment with testosterone during
the neonatal period [15]. Therefore, the levels of gonadal
steroids in a developmentally critical period may deter-
mine the fate of the BNST neurons under development
that is committed to become CRF-expressing neurons in
adulthood.
Although the structure and function of the BNST have
been studied extensively in the rat, the use of mice is be-
coming much more important for the functional analysis
of a particular neuronal population in the brain. Mice
can be genetically manipulated, and genetically engi-
neered mice are becoming indispensable tools for both
anatomical and physiological studies of the brain. With
the use of a diver mouse line, in combination with viral
vectors, pathway tracing of a particular class of neurons
is possible [16]. Opto- or chemogenetic experiments
have enabled us to target selective neurons in the mouse
brain and control them with high temporal and spatial
precision [17]. The present study was aimed at elucidat-
ing the morphological characteristics of CRF neurons in
the dorsolateral BNST of mice, paying particular atten-
tion to its sexual difference and the effects of gonadal
steroids, and the CRF-VenusΔNeo mouse was employed
to this end. First, the changes in the BNST morphology
were observed across postnatal stages until adulthood to
elucidate the time course of development of the sexual
dimorphism of CRF neurons. Second, gonadectomy
(GDX) was carried out in adult male and female mice to
examine the effects of sex steroids on the morphology of
BNST CRF neurons. The present study may provide a
structural basis for studying the role of BNST in
sex-dependent emotional behaviors in the mouse.
Methods
Animals
All animal procedures were approved by the Committee
on Use and Care of Animals, Tohoku University. The
CRF-VenusΔNeo mice were used [8, 9]. The CRF-Venus
mouse was generated in our laboratory by inserting the
Venus gene into the CRF gene by homologous recom-
bination [8]. However, Venus-expressing neurons did
not always co-express CRF in the CRF-Venus mouse [8].
We then generated the CRF-VenusΔNeo by deleting the
Neo cassette from the genome of the CRF-Venus mouse.
In the CRF-VenusΔNeo mouse, the intensity of Venus
expression is profoundly increased compared with the
CRF-Venus mouse, and most Venus-expressing neurons
co-express CRF mRNA not only in the PVH but also in
other brain regions, including the BNST [9]. The ani-
mals were allowed free access to chews (Labo MR Stock,
NOSAN Co., Yokohama, Japan) and water and were
maintained on a 12-h light/dark cycle (lights on 07:00–
19:00) at a constant temperature of 23 °C and 40–50%
humidity. For observation of Venus-expressing neurons
of the BNST over the course of development, postnatal
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day 2 (P2) (n = 5), P5 (n = 7), and 3-month-old male and
female mice (n = 4) were used in histological experi-
ments. P2 was chosen as the pre-apoptotic stage and P5
as the peak of the apoptotic stage of development, ac-
cording to the study by Gotsiridze and colleagues [18].
GDX was carried out on 3-month-old male (n = 7) and
female mice (n = 8) under anesthesia with a combination
of 3 μg medetomidine, 40 μg midazolam, and 50 μg butor-
phanol per 10 g body weight. Orchiectomy (ORX) was
carried out by the inguinal approach. The testicle was ex-
posed by pulling the vas deferens through the skin inci-
sion. After the vas deferens was ligated and severed, the
testicle was removed. The contralateral testicle was re-
moved in the same manner. Ovariectomy (OVX) was car-
ried out by the dorsolateral approach. After
identifying the ovary in the retroperitoneal adipose
tissue, a suture was made around the distal uterine
horn, and the ovary was removed. The contralateral
ovary was removed in the same manner. Male and fe-
male mice for the gonadally intact groups (n = 8 for
each group) underwent sham surgery. After surgery,
2–3 weeks were allowed for recovery, and these mice
were used for the morphometrical experiments. For
identifying the proestrous stage, vaginal smears were
taken for 14 consecutive days, and the estrous cycles
were determined [19].
Tissue preparation, immunofluorescence, and
immunohistochemistry
Mice were deeply anesthetized with chloral hydrate (400
mg/kg body weight, intraperitoneally) and perfused with
0.9% saline followed by 4% paraformaldehyde (PFA) in
0.1M phosphate buffer (PB, pH 7.4). The brain was
post-fixed overnight in 4% PFA and stored in 30% su-
crose in 10 mMPB (pH 7.4) at 4 °C for 48 h.
Thirty-micrometer-thick sections were serially cut on a
cryostat, and the free-floating sections were rinsed in 10
mM phosphate-buffered saline (PBS) (pH 7.4). For the
immunofluorescence, the sections were incubated for 30
min with 1% normal donkey or goat serum diluted in
PBS containing 0.1% (w/v) Triton X-100 (PBS-T) after
being washed with PBS-T. The sections were then incu-
bated overnight at 4 °C with rabbit anti-GFP (1:2000, Dr.
Masahiko Watanabe, Hokkaido University) [20] and/or
goat anti-calbindin (as a marker for the principal nu-
cleus, 1:500; Santa Cruz Biotechnology, Dallas, TX,
USA). After being washed with PBS-T, the sections were
incubated with Alexa 488-conjugated donkey anti-rabbit
IgG (1:250; Thermo Fisher Scientific, Waltham, MA,
USA) and Alexa 594-conjugated donkey anti-goat IgG
(1:1000; Thermo Fisher Scientific) for 2 h at room
temperature and then washed with PBS-T. The sections
were mounted with Aqua-Poly/Mount (Polysciences,
Inc., Warrington, PA, USA) and imaged using a CCD
camera (Pixera 600CL, Santa Clara, CA, USA) under a
fluorescent microscope (DMR, Leica, Wetzlar,
Germany), and the number of cells was counted. We
counted the number of Venus-expressing neurons on
each side of the respective BNST region.
Immunohistochemistry was carried out to estimate
the volume of the nucleus and the number of cells in
it: the sections were incubated overnight at 4 °C with
rabbit anti-GFP (1:2000). After being washed with
PBS-T, the sections were treated with 1% H2O2 to in-
activate endogenous peroxidases. After another wash
with PBS-T, the sections were incubated with bio-
tinylated goat anti-rabbit IgG (1:1000; Vector Labora-
tories, Burlingame, CA, USA) for 2 h at room
temperature, rinsed with PBS-T, and incubated with
avidin-biotin complex (ABC; Vector Laboratories) for
1 h at room temperature. The staining was then visu-
alized by incubating the sections in 0.05% diamino-
benzidine and 0.02% H2O2 in PBS. The sections were
spread onto amino silane-coated microscope slides,
and then, Nissl staining was carried out with thionin
solution.
Fluorescence in situ hybridization combined with
immunofluorescence
Digoxigenin (DIG)-labeled cRNA probes were synthe-
sized in vitro by transcribing the pGEM-7zf vector
(Promega, Madison, WI, USA) encoding a mouse Crf
fragment (nucleotides 138–958; GenBank accession
number, BC119036; Dr. Shuhei Horio, Tokushima
University, Japan). The sections were hybridized and
washed stringently, as was described elsewhere [20].
For immunofluorescence detection of DIG, the sec-
tions were blocked for 30 min with DIG blocking solu-
tion: Tris-HCl buffer (pH 7.4) containing 1% blocking
reagent (Roche Diagnostics, Basel, Switzerland) and
4% normal sheep serum. The sections were blocked
again with 0.5% TSA blocking reagent (PerkinElmer)
in TNT buffer for 30 min. The sections were then in-
cubated for 1 h with peroxidase-conjugated anti-DIG
(1:1000; Roche Diagnostics) and the Cy3-TSA plus
amplification kit (PerkinElmer). For immunofluores-
cence of Venus, the sections were blocked for 30 min
with normal goat serum. The sections were incubated
with rabbit anti-GFP antibody (1:2000, Dr. Watanabe)
overnight at 4 °C. After being washed with PBS-T, the
sections were incubated with Alexa 488-conjugated
donkey anti-rabbit IgG (1:250; Thermo Fisher Scien-
tific) for 2 h at room temperature and then washed with
PBS-T. The sections that were stained dually with fluor-
escence in situ hybridization and immunofluorescence
were mounted with Aqua-Poly/Mount (Polysciences,
Inc.) and imaged by a confocal laser-scanning microscope
(TCS SPE, Leica).
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Morphometrical analysis by stereology
In another set of experiments, stereology was used to es-
timate the number of Venus-expressing neurons and the
total number of neurons or glial cells in ovBNST and
alBNST, as well as the volume of each subnucleus. These
parameters were examined in gonadally intact males
(Sham-orchiectomized), orchiectomized males, proes-
trous females (Shan-ovarictomized), or ovariectomized
females. Thirty-μm sections were collected every 90 μm
from 0.38 to 0.02 mm posterior to the bregma [21], and
they were co-stained with anti-GFP antibody and thio-
nin. After staining the Venus-expressing neurons with
DAB, the sections were washed with distilled water, and
then the sections were incubated with 0.5% thionin solu-
tion (pH 4.5) for 10 min. After washing with distilled
water, the sections were dehydrated in alcohol series.
The sections were finally mounted with Entellan New
(Merck Millipore, Burlington, MA, USA). Stereological
analysis was carried out using Stereo Investigator soft-
ware (MBF Bioscience Inc., Williston, VT, USA). We
used the optical fractionator method according to the
system workflow of Stereo Investigator. We first traced
the outlines of ovBNST and alBNST on the left side of
each section to calculate the volume of the selected area
and the number of cells within the area. We defined
each subnucleus in the BNST in thionin-stained sections
according to Ju and colleagues [10, 22]. Each subnucleus
could be discriminated from the other without difficulty
in reference to the cytoarchitectonic and morphological
characteristics of the cells [10, 22]; whereas ovBNST
neurons were tightly packed, and their nuclei were
round-shaped, alBNST neurons were small-sized and
distributed sparsely. Cells could be defined as neurons
by the densely thionin-stained cytoplasm, containing an
oval- or spherical-shaped nucleus with a clear nucleolus.
The nucleus of a glial cell was smaller and stained
densely with thionin, while its cytoplasm was
barely stained [23]. Cells were excluded from either cat-
egory when they were located near the capillaries and
could potentially be endothelial cells.
Statistical analysis
For all statistical analyses, we used GraphPad Prism 7 soft-
ware (GraphPad Software, Inc., La Jolla, CA, USA). Stu-
dent’s t-test was used for analyzing the differences in the
number of Venus-expressing neurons between adult male
and female mice in the dorsolateral-, anterodorsal-, and
ventral BNST. Two-way analysis of variance (ANOVA)
was used to determine the effects of age and sex on the
number of Venus-expressing neurons across developmen-
tal stages. Two-way ANOVA was also used to determine
the effects of sex and GDX on the number of
Venus-expressing neurons, the total number of neurons
or glial cells, and the volume of the subnucleus in either
ovBNST or alBNST, as well as to determine the effects of
sex and location (subnucleus) on the number of
Venus-expressing neurons in either intact or gonadecto-
mized mice. If there was a significant interaction between
the factors, Tukey’s multiple comparisons test was carried
out as a post-hoc analysis. All data are shown as the mean
± SEM. Statistical differences were considered significant
at p < 0.05.
Results
Distribution of Venus-expressing neurons in the BNST
To elucidate the localization of CRF neurons in the
BNST, we carried out immunofluorescence and exam-
ined the distribution of Venus-expressing neurons using
the CRF-VenusΔNeo mice. Venus-expressing neurons
were distributed broadly in the anterior division of the
BNST that includes the dorsolateral BNST, the antero-
dorsal BNST, and the ventral BNST (Fig. 1a). It was re-
vealed by confocal microscopy that most Venus-
expressing neurons were co-localized with Crf mRNA in
the BNST. As was shown in Fig. 1b, for example, almost
all Venus-expressing neurons co-expressed Crf mRNA
in the dorsolateral BNST. Although a small number of
Crf mRNA-positive neurons were devoid of Venus, a
great majority of Crf mRNA-positive neurons
co-expressed Venus. Therefore, Venus-expressing neu-
rons were considered to represent CRF-producing
neurons.
Topographical localization of the Venus-expressing
neurons was examined with the double immunofluores-
cence of Venus and calbindin D-28k and the immuno-
histochemistry of Venus in combination with Nissl
staining. Calbindin D-28k is a calcium-binding protein
utilized as a marker for the gamma-aminobutyric
acid (GABA)-containing interneurons, but it is also a
marker for the principal nucleus of the BNST [24]. To
examine whether Venus-expressing (CRF) neurons all
belong to a distinctive group of neurons in the dorsolat-
eral BNST, or whether part of them belong to the princi-
pal nucleus, double immunofluorescence was carried out
with anti GFP- and anti-calbindin antibody from the an-
terior to the posterior division of the BNST (Fig. 2b, c).
Another purpose of this study was to examine whether
CRF neurons in the dorsolateral BNST that are known
to contain GABA [9] also express calbindin or not. As
shown in Fig. 2b, a cluster of Venus-expressing neurons
was observed clearly in the dorsolateral BNST. Remark-
ably Venus-expressing neurons in females outnumbered
those in males in the dorsolateral BNST (Fig. 2b). A small
number of calbindin-immunoreactive neurons could be ob-
served in the same section, but this group of cells was not a
continuum of a cluster of calbindin-positive neurons in the
principal nucleus. Venus-expressing neurons never
co-expressed calbindin immunoreactivity in the dorsolateral
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BNST (Fig. 2b). The principal nucleus could be identified
clearly by calbindin immunostaining, and the number of
calbindin-positive neurons was much greater in males than
in females in this nucleus (Fig. 2c). However, very few
Venus-expressing neurons were observed in this region, and
they never co-localized with calbindin (Fig. 2c). Thus, the
CRF neurons in the dorsolateral BNST belong to a
Fig. 1 Distribution of Venus-expressing neurons in the anterior division
of the BNST and co-localization of Venus immunofluorescence with Crf
mRNA in the dorsolateral BNST. a Photomicrograph showing the Venus-
expressing neurons in the anterior division of the BNST. White dashed
lines indicate the boundaries of the subnuclei in the anterior BNST. LV,
lateral ventricle; ovBNST, oval nucleus of the BNST; alBNST, anterolateral
BNST; AC, anterior commissure; POA; anterior preoptic area; ic, internal
capsule. Scale bar = 200 µm. b Confocal images showing Venus
(immunofluorescence, upper left panel) and Crf (fluorescence in situ
hybridization, upper right panel) in the dorsolateral BNST. The Venus and
Crf are shown as green and red, respectively. The lower left panel shows
a merged image of Venus and Crf mRNA. Scale bar = 100 μm
Fig. 2 Differential distribution of Venus-expressing neurons in
dorsolateral BNST and calbindin-positive neurons in the principal
nucleus of the BNST in the mouse. a A diagram illustrating the
cytoarchitecture of the anterior and posterior divisions of the BNST
in coronal sections. LV, lateral ventricle; ic, internal capsule; AC,
anterior commissure. The area in red shows the dorsolateral BNST,
blue the anterodorsal BNST, green the ventral division of the BNST,
and yellow the principal nucleus of the BNST. b Photomicrographs
showing double immunofluorescence for Venus-expressing neurons
(green) and calbindin-positive neurons (red) in the dorsolateral BNST.
c Photomicrographs showing Venus-expressing neurons (green) and
calbindin-positive neurons (red) in the principal nucleus. The right-
most panels show the merged images of Venus-expressing and
calbindin-positive neurons. Scale bar = 100 μm
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distinctive group of neurons which is completely different
from the principal nucleus.
To confirm the female-biased sexual dimorphism in
the number of CRF neurons in the dorsolateral BNST
(vide supra), and to examine whether the female pre-
dominance is confined to the area, we counted the num-
ber of Venus-expressing neurons in the dorsolateral-,
anterodorsal-, and ventral BNST in both sexes in adult-
hood (at 3 months of age). There was approximately
1.5-fold as many Venus-expressing neurons in females
as in males in dorsolateral BNST (female 613 ± 55 cells
vs. male 423 ± 28 cells, p < 0.05; Fig. 3a). However, there
were no significant differences in the number of
Venus-positive neurons between males and females in
the anterodorsal and ventral BNST (Fig. 3a). Therefore,
the dorsolateral BNST is the only region that showed a
female-biased sex difference.
We sought to examine at what developmental stage the
female-biased sex difference becomes evident in the dorso-
lateral BNST. The BNST neurons undergo apoptosis dur-
ing the developmental course, so we examined the mice at
P2 (before the peak of apoptosis) and P5 (at the peak of
apoptosis), as compared with those at 3months of age. The
number of Venus-expressing neurons increased over the
course of development, from P2 to 3months, but there was
no significant sex difference from P2 to P5 (Fig. 3b). The
number of Venus-expressing neurons increased dramatically
thereafter, and the female predominance became evident in
adulthood (3months of age) (Fig. 3b). Two-way ANOVA in-
dicated a significant interaction between sex and age (F (2,
26) = 4.903, p < 0.05), as well as the main effects of sex (F (1,
26) = 18.2, p < 0.001) and age (F (2, 26) = 154.6, p < 0.0001).
Tukey’s multiple comparisons test indicated that the
number of Venus-expressing neurons was significantly
greater in 3-month-old male- vs. P2 (p < 0.001) and
P5 male mice (p < 0.001) and significantly greater in
3-month-old female- vs. P2 (p < 0.0001) and P5 fe-
male mice (p < 0.001) (Fig. 3b). The number of
Venus-expressing neurons was significantly greater in
3-month-old female vs. 3-month-old male (p < 0.01)
(Fig. 3b).
Effects of gonadal steroids on the number of Venus-
expressing neurons in the dorsolateral BNST
GDX was carried out in both male and female mice at 3
months of age to examine whether the sex differences in
the dorsolateral BNST are affected by gonadal steroids. The
diagram in Fig. 4a illustrates the cytoarchitecture within the
dorsolateral BNST that comprises alBNST and ovBNST. As
shown in Fig. 4b, the number of Venus-expressing neurons
decreased markedly in ovariectomized females in compari-
son with proestrous females. In contrast, the number of
Venus-expressing neurons increased markedly in the
dorsolateral BNST in orchiectomized males compared with
gonadally intact males.
We next analyzed the data in alBNST and ovBNST,
using the stereological method, to estimate the number
of Venus-expressing neurons, as well as total number of
neurons, in each subnucleus, the volume of each subnu-
cleus, and the number of glial cells in respective subnuclus,
in four groups of animals, i.e., gonadally intact males,
orchiectomized males, proestrous females, and ovariecto-
mized females. In ovBNST, two-way ANOVA indicated
a significant interaction, for the number of
Venus-expressing neurons, between sex and GDX (F
(1, 27) = 45.81, p < 0.0001). Tukey’s multiple compari-
sons indicated that the number of Venus-expressing neu-
rons was significantly greater in proestrous females vs.
intact males (p < 0.0001), significantly greater in proes-
trous females vs. ovariectomized females (p < 0.0001), and
significantly greater in orchiectomized males vs. intact
males (p < 0.01) (Fig. 5a). Unexpectedly, the number of
Fig. 3 Sex differences in the number of Venus-expressing neurons in the subnuclei of the anterior division of BNST. a The number of Venus-
expressing neurons in adult male and female mice. *p < 0.0001 vs. male in the dorsolateral BNST. b The changes in the number of Venus-
expressing neurons in the dorsolateral BNST from early postnatal stages to adulthood. Two-way ANOVA indicated the main effect of sex or age
on the number of Venus-expressing neurons in the dorsolateral BNST. *p < 0.001 vs. P2 male mice; †p < 0.001 vs. P5 male mice; ‡p < 0.0001 vs. P2
female mice; §p < 0.001 vs. P5 female mice; ¶p < 0.01 vs. 3 month-old male mice (the data of adult male mice in b are the same as the
dorsolateral data in a. Data are shown as the means ± SEM
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Venus-expressing neurons was greater significantly in
orchiectomized males vs. ovariectomized females (p <
0.01) (Fig. 5a). In alBNST, two-way ANOVA also
indicated a significant interaction between sex and
GDX (F (1, 27) = 8.943, p < 0.01). Tukey’s multiple
comparisons test indicated that the number of
Venus-expressing neurons was significantly greater in
proestrous females vs. intact males (p < 0.05) and sig-
nificantly greater in proestrous females vs.
ovariectomized females (p < 0.05) (Fig. 5b). There was
no significant difference, in the number of Venus-
expressing neurons, between intact males and ovariec-
tomized females, or between orchiectomized males
and proestrous females, in either ovBNST or alBNST
(Fig. 5b).
We also analyzed the number of Venus expressing
neurons in intact male and proestrous female mice or
gonadectomized male and female mice, with respect to
the effects of location and sex (not shown in Figures).
For intact males and proestrous females, two-way
ANOVA indicated a significant main effect of sex (more
predominant in females than in males) (F (1, 28) =
44.37, p < 0.0001) and a significant main effect of loca-
tion (more predominant in ovBNST than in alBNST) (F
(1, 28) = 36.34, p < 0.0001), but there was no interaction
between location and sex. There were also significant
main effects of sex (more predominant in females) and
location (more predominant in ovBNST), without an
interaction between sex and location, in gonadectomized
mice (data not shown).
Next, the effect of sex or GDX on the total number of
neurons was analyzed in the dorsolateral BNST subnu-
clei. Two-way ANOVA indicated a significant main ef-
fect of sex in either ovBNST (F (1, 27) = 5.021, p < 0.05)
or alBNST (F (1, 27) = 4.519, p < 0.05). However, there
was no interaction between sex and GDX in either
ovBNST or alBNST, nor was there a main effect of GDX
in either ovBNST (F (1, 27) = 0.3381, p = 0.57) or
alBNST (F (1, 27) = 1.204, p = 0.28). An analysis was
made for the effect of sex or GDX on the volumes of
dorsolateral BNST subnuclei. Two-way ANOVA indi-
cated a significant main effect of sex in either ovBNST
(F (1, 28) = 9.268, p < 0.01) or alBNST (F (1, 27) =
4.903, p < 0.05). However, there was no interaction be-
tween sex and GDX in either ovBNST or alBNST, nor
was there a main effect of GDX in either ovBNST (F (1,
28) = 0.003, p = 0.96) or alBNST (F (1, 27) = 0.3989, p =
0.53).There was no effect of sex or GDX on the number
of glial cells in either alBNST or ovBNST (Fig. 5g, h).
Discussion
We showed for the first time that CRF neurons in the two
BNST subnuclei of the mouse, i.e., ovBNST and alBNST,
show a female-biased sexual dimorphism using a mouse
line in which Venus is driven by the Crf promotor. The
present results are consistent with previous reports in the
rat [14, 15], reinforcing the female predominance in the
number of BNST CRF neurons across species. CRF neu-
rons that were identified by Venus expression are mostly
confined to the anterior division of the BNST, consistent
with the previous reports in the rat [6, 10]. We showed
further that they constitute a distinct population from the
principal nucleus of the BNST, which is a well-known
Fig. 4 The effect of gonadectomy on the morphology of Venus-
expressing neurons in the dorsolateral BNST. a A diagram illustrating the
cytoarchitecture of dorsal BNST subnuclei, on the right side of a coronal
section of the anterior division of the BNST. An enlarged illustration on
the right-hand side depicts the dorsolateral BNST in more detail. al,
anterolateral BNST; ov, oval nucleus of the BNST; ad, anterodorsal BNST;
LV, lateral ventricle; AC, anterior commissure; ic, internal capsule. b
Comparison of Venus-expressing neurons in the dorsolateral BNST
between gonadally intact- and gonadectomized mice. Venus-expressing
neurons are stained with immunohistochemistry (brown-colored), and
subsequently, Nissl staining was carried out using the same section to
identify the subnuclei of the BNST. Venus-expressing neurons were
stained more intensely not only in the soma but also in the fibers in
proestrous female mice compared with intact males. AC, anterior
commissure; ic, internal capsule; LV, lateral ventricle. Scale bar = 200 μm
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male-biased sexual dimorphic nucleus [24–26]. In the
present study, the number of Venus-expressing neurons
was greater in ovBNST compared with alBNST, recapitu-
lating the previous observations in the rat that CRF neu-
rons are expressed most prominently in ovBNST [6, 11].
Remarkably, the number of Venus-expressing neu-
rons changed markedly by the elimination of sex ste-
roids by GDX in adult male and female mice. In
females, the number of Venus-expressing neurons de-
creased significantly in ovBNST and alBNST following
OVX. In males, the number of Venus-expressing neu-
rons increased in these subnuclei following ORX, al-
though the changes were statistically significant only
in the ovBNST. Thus, GDX brought about a change
in the number of Venus-expressing neurons in an op-
posite direction between males and females. It is un-
likely that an absence of gonadal steroids in
adulthood elicits either apoptosis or mitotic division
of CRF neurons, so the apparent changes in the num-
ber of Venus-expressing neurons, observed in the
present study, were considered to have resulted from
the changes in expression levels of cytoplasmic Venus
content which was dependent on the CRF promoter
activity. This idea was reinforced by an observation that
the total number of neurons and the volume of the nucleus
were not affected significantly by GDX. Unexpectedly, the
number of Venus-expressing neurons in the orchiecto-
mized male group was significantly greater than that in the
ovariectomized female group. It is not clear whether this
‘reverse effect’ of GDX is based on the genetic- or
Fig. 5 Effects of sex or gonadectomy on the morphological
features of Venus-expressing neurons in alBNST or ovBNST. Effects
of sex or GDX on the number of Venus-expressing neurons in
ovBNST (a) or alBNST (b). Groups of Sham-orchiectomized males
(intact), orchiectomized males (ORX), Sham-ovariectomized
proestrous females (proestrous), and ovariectomized females (OVX)
were analyzed by two-way ANOVA. There was a significant
interaction between sex and GDX in both subnuclei. Multiple
comparisons test indicated female predominance in the number of
Venus-expressing neurons in either ovBNST or alBNST. ovBNST:
*p < 0.01 vs. intact males, **p < 0.0001 vs. intact males, †p < 0.0001
vs. proestrous females, ‡p < 0.01 vs. ORX. alBNST: *p < 0.05 vs. intact
males, †p < 0.05 vs. proestrous females. Effects of sex or GDX on
the total number of neurons in ovBNST (c) or alBNST (d). As
regards the total number of neurons, there was a significant main
effect of sex in either ovBNST (c) or alBNST (d), but there was no
interaction between sex and GDX, nor was these a main effect of
GDX. *, p < 0.05. Effects of sex or GDX on the volume of ovBNST
(e) or alBNST (f). There was a significant main effect of sex on the
volume of the nucleus in either ovBNST (e) or alBNST (f), but there
was no an interaction between sex and GDX, nor was these a main
effect of GDX. **, p < 0.01, *, p < 0.05. Effects of sex or GDX on the
number of glia in ovBNST (g) or alBNST (h). Neither an interaction
between sex and GDX nor a significant main effect of sex or GDX
was observed for the number of glial cells in either ovBNST (g) or
alBNST (h)
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epigenetic difference (dependent on perinatal gonadal hor-
mone levels) between the sexes.
It was also shown in the present study that the num-
ber of Venus-expressing neurons in the dorsolateral
BNST increased markedly during the course of early de-
velopment till adulthood. In the mouse BNST, neurons
had already been postmitotic by embryonic day 15.5
[27]. Maturation of BNST is then accomplished by apop-
totic cell death that reaches the peak at P5, and the
number of neurons stabilizes thereafter [28]. There-
fore, the postnatal increase in the number of
Venus-expressing neurons is unrelated to the mitotic in-
crement of CRF neurons, and it must have resulted from
the activation of Crf promoter during development. The
Crf mRNA expression was also markedly increased post-
natally in the hypothalamus and the amygdala in rodents
[29, 30], so the increase in CRF expression during devel-
opment may not be specific for the BNST.
Since both alpha and beta subtypes of the estrogen re-
ceptor are distributed across dorsolateral BNST [31], es-
trogen is capable of affecting CRF neurons located in the
region. Multiple estrogen response element half-sites are
present upstream of the Crf open-reading frame [32].
Crf promoter activity may be activated by estrogen since
Crf gene expression was decreased by OVX in the
mouse PVH, and treatment of ovariectomized females
with estradiol led to a recovery of Crf expression within
12 h [33]. Androgen receptors are also distributed
throughout the dorsolateral BNST [34], and an androgen
response element-like sequence is present upstream of the
Crf open-reading frame [35]. Therefore, testosterone may
possibly suppress Crf promoter activity directly. It was
reported in the rat that the exposure to testosterone at an
early postnatal stage abolishes the female-biased sexual
dimorphism in the BNST [15], suggesting a role of andro-
gen in the sex-dependent differentiation of the BNST.
Since estrogen can be produced by conversion of testos-
terone by tissue aromatase, it is not clear whether andro-
gen exerts its effect directly via androgen receptors, or
whether estrogen is responsible, in the regulation of tran-
scription process, for inducing the sexual dimorphism of
the BNST [36].
In addition to the sex difference in the number of
Venus-expressing neurons, the total number of neu-
rons was also significantly greater in females than in
males in either ovBNST or alBNST, yet the number
of neurons was unaffected by the absence of gonadal
steroids in either sex in adulthood. This is consistent
with the previous report in the rat that the number
of neurons was greater in females in the anterior re-
gion of the lateral division of BNST [37], which is
identical to the ovBNST in the present nomenclature.
Interestingly, the number of neurons in this subnu-
cleus was greater in 3-month-old male rats that
underwent ORX on the day of birth than in control
males [37]. Conversely, the number of neurons was
smaller in females which had been injected with tes-
tosterone on the day of birth compared with control
females [37]. Therefore, female-biased sexual di-
morphism in this nucleus was dependent on gonadal
steroid levels at an early developmental stage in the
rat; we assume that the female predominance in the
total number of neurons in the mouse ovBNST and
alBNST, observed in the present study, may also be
related to the early postnatal exposure to gonadal ste-
roids. The female-biased sexual dimorphism of the
dorsolateral BNST makes a contrast to the
well-recognized male-biased sexual dimorphism of the
principal nucleus which is located just rostral to the
dorsolateral BNST.
The dorsolateral BNST is one of the relay centers for in-
tegrating emotional responses including anxiety and fear
[12, 38]; it receives neural projections from the cortical,
limbic, and brain stem regions and projects directly to the
hypothalamic and midbrain/brainstem regions, which give
rise to emotional or autonomic outflows [39–41]. Al-
though the BNST is a composite structure containing
multiple neuronal species, CRF neurons in the BNST are
specifically implicated in stress- and anxiety-related be-
haviors in this nucleus [42]. Recently, it was reported that
selective activation of ovBNST, by optogenetic methods,
elicits anxiogenic responses [41, 43], reinforcing the hy-
pothesis that the CRF neurons in ovBNST may be in-
volved in the processing of anxiety-like behavior.
It is well-documented that anxiety-related behaviors are
dependent on the levels of gonadal steroids in adulthood;
for example, GDX is associated with increased anxiety in
adult male rats [44, 45], and this can be reversed by testos-
terone supplementation [44, 46, 47]. However, it is not clear
what brain region(s) is responsible for the gonadal
steroid-dependent anxiety-like behavior. Since expression
of CRF in the dorsolateral BNST is regulated robustly by
gonadal steroid, it is tempting to speculate that the CRF
neurons in the dorsolateral BNST may be related in part to
the sex difference in fear and/or anxiety responses under
stress, as well as related pathological conditions, such as
anxiety disorders or depression [48–51].
To understand the sexual difference in brain func-
tion, it is imperative to understand the morphological
differences between the male and female brain in de-
tail, and sexually dimorphic nuclei are the best targets
to explore in the first place. Thus, a morphological
study of sex differences in the BNST is key for re-
vealing the mechanisms of local handling of emo-
tional information such as fear and anxiety, and in
this context, further studies are required to unravel
the functional significance of the female-biased ex-
pression of CRF neurons in dorsolateral BNST.
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Conclusion
Our findings indicated that Venus-expressing CRF neurons
present a female-biased sexual dimorphism in ovBNST and
alBNST, two subnuclei in the dorsolateral BNST. The ab-
sence of gonadal steroids in adulthood abolished the
female-biased sex difference in the number of
Venus-expressing neurons. Thus, the Crf promoter activity
in the dorsolateral BNST was highly dependent on gonadal
steroids. CRF neurons expressed in the BNST are impli-
cated in the anxiety-like behavior, and we speculate that the
female-biased expression of CRF in the dorsolateral BNST
may possibly be related to the sex differences in the pro-
cessing of emotional responses including anxiety.
Abbreviations
alBNST: Anterolateral BNST; ANOVA: Analysis of variance; BNST: Bed nucleus
of the stria terminalis; CeA: Central nucleus of the amygdala;
CRF: Corticotropin-releasing factor; GABA: Gamma-aminobutyric acid;
GDX: Gonadectomy; GFP: Green fluorescent protein; ovBNST: Oval nucleus of
the BNST; OVX: Ovariectomy; P2: Postnatal day 2; P5: Postnatal day 5;
PVH: Paraventricular nucleus of the hypothalamus; Venus: Modified yellow
fluorescent protein
Acknowledgements
We thank Dr. Masahiko Watanabe (Hokkaido University) and Dr. Shuhei Horio
(Tokushima University) for kindly donating the anti-GFP antibody and the
plasmid containing a mouse Crf cDNA fragment.
Funding
This research was supported by a research grant from Graduate School of
Information Sciences, Tohoku University (to KU) and was supported in part
by JSPS KAKENHI No. 16K09793 (to KU).
Availability of data and materials
The datasets generated and analyzed during the current study are available
from the corresponding author on reasonable request.
Authors’ contributions
KU designed the study, collected the data and analyzed and interpreted
them, and wrote the manuscript. HO collected, analyzed, and interpreted the
data. MM and ST analyzed and interpreted the data, and they also
contributed to the discussion. TS contributed to the discussion. KS and KI
developed the CRF-Venus and CRF-VenusΔNeo mice. KI interpreted the data
and wrote the manuscript. All authors read and approved the final
manuscript.
Ethics approval and consent to participate
All animal procedures were approved by the Committee on Use and Care of
Animals, Tohoku University. The protocol for animal experiment was
approved by the Center for Laboratory Animal Research, Tohoku university,
reference number 2017IsA-002.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Laboratory of Information Biology, Graduate School of Information Sciences,
Tohoku University, Sendai City, Japan. 2Department of Regulation Biology,
Graduate School of Science and Engineering, Saitama University, Saitama
City, Japan. 3Department of Cellular Neurobiology, Brain Research Institute,
Niigata University, Niigata City, Japan.
Received: 3 March 2018 Accepted: 6 January 2019
References
1. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine
hypothalamic peptide that stimulates secretion of corticotropin and beta-
endorphin. Science. 1981;213(4514):1394–7.
2. Demeulemeester H, Vandesande F, Orban GA, Brandon C, Vanderhaeghen
JJ. Heterogeneity of GABAergic cells in cat visual cortex. J Neurosci. 1988;
8(3):988–1000.
3. Kitahama K, Luppi PH, Tramu G, Sastre JP, Buda C, Jouvet M. Localization of
CRF-immunoreactive neurons in the cat medulla oblongata: their presence
in the inferior olive. Cell Tissue Res. 1988;251(1):137–43.
4. Valentino RJ, Page ME, Luppi PH, Zhu Y, Van Bockstaele E, Aston-Jones G.
Evidence for widespread afferents to Barrington’s nucleus, a brainstem
region rich in corticotropin-releasing hormone neurons. Neuroscience. 1994;
62(1):125–43.
5. Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organization of ovine
corticotropin-releasing factor immunoreactive cells and fibers in the rat brain:
an immunohistochemical study. Neuroendocrinology. 1983;36(3):165–86.
6. Moga MM, Saper CB, Gray TS. Bed nucleus of the stria terminalis:
cytoarchitecture, immunohistochemistry, and projection to the parabrachial
nucleus in the rat. J Comp Neurol. 1989;283(3):315–32.
7. Biag J, Huang Y, Gou L, Hintiryan H, Askarinam A, Hahn JD, Toga AW, Dong
HW. Cyto- and chemoarchitecture of the hypothalamic paraventricular
nucleus in the C57BL/6J male mouse: a study of immunostaining and
multiple fluorescent tract tracing. J Comp Neurol. 2012;520(1):6–33.
8. Itoi K, Talukder AH, Fuse T, Kaneko T, Ozawa R, Sato T, Sugaya T, Uchida K,
Yamazaki M, Abe M, et al. Visualization of corticotropin-releasing factor
neurons by fluorescent proteins in the mouse brain and characterization of
labeled neurons in the paraventricular nucleus of the hypothalamus.
Endocrinology. 2014;155(10):4054–60.
9. Kono J, Konno K, Talukder AH, Fuse T, Abe M, Uchida K, Horio S, Sakimura K,
Watanabe M, Itoi K. Distribution of corticotropin-releasing factor neurons in
the mouse brain: a study using corticotropin-releasing factor-modified
yellow fluorescent protein knock-in mouse. Brain Struct Funct. 2017;222(4):
1705–32.
10. Ju G, Swanson LW, Simerly RB. Studies on the cellular architecture of the
bed nuclei of the stria terminalis in the rat: II. Chemoarchitecture. J Comp
Neurol. 1989;280(4):603–21.
11. Shi C, Davis M. Pain pathways involved in fear conditioning measured with
fear-potentiated startle: lesion studies. J Neurosci. 1999;19(1):420–30.
12. Walker DL, Toufexis DJ, Davis M. Role of the bed nucleus of the stria
terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol.
2003;463(1–3):199–216.
13. McMenamin BW, Langeslag SJ, Sirbu M, Padmala S, Pessoa L. Network
organization unfolds over time during periods of anxious anticipation. J
Neurosci. 2014;34(34):11261–73.
14. Funabashi T, Kawaguchi M, Furuta M, Fukushima A, Kimura F. Exposure to
bisphenol A during gestation and lactation causes loss of sex difference in
corticotropin-releasing hormone-immunoreactive neurons in the bed
nucleus of the stria terminalis of rats. Psychoneuroendocrinology. 2004;
29(4):475–85.
15. Fukushima A, Furuta M, Kimura F, Akema T, Funabashi T. Testosterone
exposure during the critical period decreases corticotropin-releasing
hormone-immunoreactive neurons in the bed nucleus of the stria terminalis
of female rats. Neurosci Lett. 2013;534:64–8.
16. Harris JA, Oh SW, Zeng H: Adeno-associated viral vectors for anterograde
axonal tracing with fluorescent proteins in nontransgenic and Cre driver
mice. Curr Protoc Neurosci 2012, Chapter 1:Unit 1 20 21–18.
17. Zeng H, Madisen L. Mouse transgenic approaches in optogenetics. Prog
Brain Res. 2012;196:193–213.
18. Gotsiridze T, Kang N, Jacob D, Forger NG. Development of sex differences in
the principal nucleus of the bed nucleus of the stria terminalis of mice: role
of Bax-dependent cell death. Dev Neurobiol. 2007;67(3):355–62.
19. Caligioni CS. Assessing reproductive status/stages in mice. Curr Protoc
Neurosci. 2009;Appendix 4:Appendix 4I.
Uchida et al. Biology of Sex Differences            (2019) 10:6 Page 10 of 11
20. Yamasaki M, Yamada K, Furuya S, Mitoma J, Hirabayashi Y, Watanabe M. 3-
Phosphoglycerate dehydrogenase, a key enzyme for l-serine biosynthesis, is
preferentially expressed in the radial glia/astrocyte lineage and olfactory
ensheathing glia in the mouse brain. J Neurosci. 2001;21(19):7691–704.
21. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates,
compact. 2nd ed. Amsterdam; Boston: Elsevier Academic Press; 2004.
22. Ju G, Swanson LW. Studies on the cellular architecture of the bed nuclei of
the stria terminalis in the rat: I. Cytoarchitecture. J Comp Neurol. 1989;
280(4):587–602.
23. Moe Y, Kyi-Tha-Thu C, Tanaka T, Ito H, Yahashi S, Matsuda KI, Kawata M,
Katsuura G, Iwashige F, Sakata I, et al. A sexually dimorphic area of the
dorsal hypothalamus in mice and common marmosets. Endocrinology.
2016;157(12):4817–28.
24. Wittmann W, McLennan IS. The bed nucleus of the stria terminalis has
developmental and adult forms in mice, with the male bias in the
developmental form being dependent on testicular AMH. Horm Behav.
2013;64(4):605–10.
25. Moe Y, Tanaka T, Morishita M, Ohata R, Nakahara C, Kawashima T, Maekawa
F, Sakata I, Sakai T, Tsukahara S. A comparative study of sex difference in
calbindin neurons among mice, musk shrews, and Japanese quails. Neurosci
Lett. 2016;631:63–9.
26. Tsukahara S. Sex differences and the roles of sex steroids in apoptosis of
sexually dimorphic nuclei of the preoptic area in postnatal rats. J
Neuroendocrinol. 2009;21(4):370–6.
27. Tinterri A, Deck M, Keita M, Mailhes C, Rubin AN, Kessaris N, Lokmane L,
Bielle F, Garel S. Tangential migration of corridor guidepost neurons
contributes to anxiety circuits. J Comp Neurol. 2018;526(3):397–411.
28. Chung WC, Swaab DF, De Vries GJ. Apoptosis during sexual differentiation
of the bed nucleus of the stria terminalis in the rat brain. J Neurobiol. 2000;
43(3):234–43.
29. Grino M, Young WS 3rd, Burgunder JM. Ontogeny of expression of the
corticotropin-releasing factor gene in the hypothalamic paraventricular
nucleus and of the proopiomelanocortin gene in rat pituitary.
Endocrinology. 1989;124(1):60–8.
30. Keegan CE, Herman JP, Karolyi IJ, O’Shea KS, Camper SA, Seasholtz AF.
Differential expression of corticotropin-releasing hormone in developing
mouse embryos and adult brain. Endocrinology. 1994;134(6):2547–55.
31. Laflamme N, Nappi RE, Drolet G, Labrie C, Rivest S. Expression and
neuropeptidergic characterization of estrogen receptors (ERalpha and
ERbeta) throughout the rat brain: anatomical evidence of distinct roles of
each subtype. J Neurobiol. 1998;36(3):357–78.
32. Chen XN, Zhu H, Meng QY, Zhou JN. Estrogen receptor-alpha and -beta
regulate the human corticotropin-releasing hormone gene through similar
pathways. Brain Res. 2008;1223:1–10.
33. Pelletier G, Li S, Luu-The V, Labrie F. Oestrogenic regulation of pro-
opiomelanocortin, neuropeptide Y and corticotrophin-releasing hormone
mRNAs in mouse hypothalamus. J Neuroendocrinol. 2007;19(6):426–31.
34. Simerly RB, Chang C, Muramatsu M, Swanson LW. Distribution of androgen
and estrogen receptor mRNA-containing cells in the rat brain: an in situ
hybridization study. J Comp Neurol. 1990;294(1):76–95.
35. Bao AM, Fischer DF, Wu YH, Hol EM, Balesar R, Unmehopa UA, Zhou JN,
Swaab DF. A direct androgenic involvement in the expression of human
corticotropin-releasing hormone. Mol Psychiatry. 2006;11(6):567–76.
36. Roselli CE, Liu M, Hurn PD. Brain aromatization: classic roles and new
perspectives. Semin Reprod Med. 2009;27(3):207–17.
37. Guillamon A, Segovia S, del Abril A. Early effects of gonadal steroids on the
neuron number in the medial posterior region and the lateral division of
the bed nucleus of the stria terminalis in the rat. Brain Res Dev Brain Res.
1988;44(2):281–90.
38. Duvarci S, Bauer EP, Pare D. The bed nucleus of the stria terminalis mediates
inter-individual variations in anxiety and fear. J Neurosci. 2009;29(33):10357–61.
39. Dong HW, Petrovich GD, Swanson LW. Topography of projections from
amygdala to bed nuclei of the stria terminalis. Brain Res Brain Res Rev. 2001;
38(1–2):192–246.
40. Dong HW, Petrovich GD, Watts AG, Swanson LW. Basic organization of
projections from the oval and fusiform nuclei of the bed nuclei of the stria
terminalis in adult rat brain. J Comp Neurol. 2001;436(4):430–55.
41. Kim SY, Adhikari A, Lee SY, Marshel JH, Kim CK, Mallory CS, Lo M, Pak S,
Mattis J, Lim BK, et al. Diverging neural pathways assemble a behavioural
state from separable features in anxiety. Nature. 2013;496(7444):219–23.
42. Walker DL, Miles LA, Davis M. Selective participation of the bed nucleus of the
stria terminalis and CRF in sustained anxiety-like versus phasic fear-like
responses. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33(8):1291–308.
43. Tovote P, Fadok JP, Luthi A. Neuronal circuits for fear and anxiety. Nat Rev
Neurosci. 2015;16(6):317–31.
44. Edinger KL, Frye CA. Intrahippocampal administration of an androgen
receptor antagonist, flutamide, can increase anxiety-like behavior in intact
and DHT-replaced male rats. Horm Behav. 2006;50(2):216–22.
45. Frye CA, Seliga AM. Testosterone increases analgesia, anxiolysis, and
cognitive performance of male rats. Cogn Affect Behav Neurosci. 2001;
1(4):371–81.
46. Carrier N, Saland SK, Duclot F, He H, Mercer R, Kabbaj M. The anxiolytic and
antidepressant-like effects of testosterone and estrogen in gonadectomized
male rats. Biol Psychiatry. 2015;78(4):259–69.
47. Khakpai F. The effect of opiodergic system and testosterone on anxiety
behavior in gonadectomized rats. Behav Brain Res. 2014;263:9–15.
48. ter Horst JP, de Kloet ER, Schachinger H, Oitzl MS. Relevance of stress and
female sex hormones for emotion and cognition. Cell Mol Neurobiol. 2012;
32(5):725–35.
49. Archer J. Sex differences in the emotional behaviour of laboratory mice. Br J
Psychol. 1977;68(1):125–31.
50. Karisetty BC, Joshi PC, Kumar A, Chakravarty S. Sex differences in the effect
of chronic mild stress on mouse prefrontal cortical BDNF levels: a role of
major ovarian hormones. Neuroscience. 2017;356:89–101.
51. Keiser AA, Turnbull LM, Darian MA, Feldman DE, Song I, Tronson NC. Sex
differences in context fear generalization and recruitment of hippocampus and
amygdala during retrieval. Neuropsychopharmacology. 2017;42(2):397–407.
Uchida et al. Biology of Sex Differences            (2019) 10:6 Page 11 of 11
